Showing results (211-220 of 461) with videos related to

Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomasStephen B Fox, Philip Brown, Cheng Han, et al.
The Journal of Pathology|May 20, 2003
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancerAlexandra Giatromanolaki, Michael I Koukourakis, Efthimios Sivridis, et al.
Oncotarget|August 26, 2015
Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibitionIoanna Ledaki, Alan McIntyre, Simon Wigfield, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancerMichael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2006
C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancerMichael I Koukourakis, Dimitrios Papazoglou, Alexandra Giatromanolaki, et al.
Cancer Research|September 23, 2003
Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patientsMichael I Koukourakis, Alexandra Giatromanolaki, Rolf A Brekken, et al.
Cancer Treatment Reviews|October 16, 2012
New strategies for targeting the hypoxic tumour microenvironment in breast cancerCarol Ward, Simon P Langdon, Peter Mullen, et al.
EJNMMI Research|June 1, 2017
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumabNeel Patel, Sarah Able, Danny Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
Cancer Research|March 15, 2008
Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cellsCassin Kimmel Williams, Marta Segarra, Maria De La Luz Sierra, et al.
Pageof 47